VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KNSA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
KNSAKiniksa Pharmaceuticals International, plc
$95.11$7.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKNSAInstitutional Holders

KNSA logoKiniksa Pharmaceuticals International, plc (KNSA) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+0.16 pp), though top 10 holders maintain a highly concentrated 54.5% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
62.0%$2.9B total value · ▲ +0.16 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
65 / 100
Bullish
Institutions & Flow265 holders+38 net flow (+65 / -27)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+38)
  • Point72 Asset Management, L.p. and Two Sigma Investments, Lp maintain significant positions
  • Top 10 holders control 54.5% of institutional value
  • No Insider Signal

Top Institutional Holders of KNSA

Ranked by reported Q2 2026 13F market value

Top 10 Holders
54.5%
Top 25 Holders
74.7%

Share of total reported institutional value in KNSA held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1FMR LLC7.0M$445.8M+2.2%9.148%0.02%
2Rubric Capital Management LP4.0M$255.8M+6.7%5.249%2.35%
3BAKER BROS. ADVISORS LP2.8M$181.3M+0.3%3.720%0.91%
4BlackRock, Inc.2.7M$175.2M+462.8%3.595%0.00%
5TANG CAPITAL MANAGEMENT LLC2.3M$144.5M0.0%2.966%6.56%
6VANGUARD PORTFOLIO MANAGEMENT LLC1.9M$122.2M+8.2%2.508%0.01%
7VANGUARD CAPITAL MANAGEMENT LLC1.4M$87.0M+2.1%1.786%0.00%
8MORGAN STANLEY1.0M$64.7M+1.3%1.327%0.00%
9ARROWSTREET CAPITAL, LIMITED PARTNERSHIP958K$61.2M+7.3%1.256%0.03%
10Spruce Street Capital LP918K$58.7M+20.6%1.205%11.52%
11DIMENSIONAL FUND ADVISORS LP875K$55.9M+7.7%1.148%0.01%
12Invesco Ltd.773K$49.4M+2694.3%1.014%0.00%
13DRIEHAUS CAPITAL MANAGEMENT LLC718K$45.9M+17.5%0.942%0.27%
14STATE STREET CORP704K$45.0M+818.9%0.924%0.00%
15Point72 Asset Management, L.P.659K$42.2M+2.9%0.865%0.05%
16RICE HALL JAMES & ASSOCIATES, LLC625K$40.0M+2.7%0.820%1.95%
17Pictet Asset Management Holding SA609K$38.9M-2.4%0.799%0.04%
18GEODE CAPITAL MANAGEMENT, LLC604K$38.6M+1263.2%0.793%0.00%
19Jupiter Topco LLC586K$37.5M—0.769%0.02%
20Connor, Clark & Lunn Investment Management Ltd.573K$36.6M-11.9%0.751%0.07%
21D. E. Shaw & Co., Inc.570K$36.4M-40.6%0.748%0.02%
22TWO SIGMA INVESTMENTS, LP561K$35.9M+33.4%0.737%0.03%
23VICTORY CAPITAL MANAGEMENT INC505K$32.3M-0.3%0.662%0.02%
24BNP PARIBAS FINANCIAL MARKETS437K$28.0M-32.5%0.574%0.01%
25MASSACHUSETTS FINANCIAL SERVICES CO /MA/431K$27.6M-1.5%0.566%0.01%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KNSA — a direct measure of their conviction.

Quarterly Institutional Activity

Filings activity in KNSA during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers65Added To152Trimmed40Exited27

New Buyers

65

Institutions that opened a new KNSA position in Q2 2026

  • STEMPOINT CAPITAL LP$13.4M
  • SEGALL BRYANT & HAMILL, LLC$4.6M
  • RENAISSANCE TECHNOLOGIES LLC$4.4M
  • TRUIST FINANCIAL CORP$3.3M
  • MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC$2.7M
  • Financial Enhancement Group LLC$2.0M
  • MetLife Investment Management, LLC$1.6M
  • Atika Capital Management LLC$1.5M
  • Sigma Planning Corp$1.3M
  • MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.$1.2M
  • CenterBook Partners LP$1.2M
  • SUPERSTRING CAPITAL MANAGEMENT LP$1.2M

Exited Positions

27

Institutions that fully closed their KNSA position in Q2 2026

  • MARSHALL WACE, LLP$14.7M
  • Parkman Healthcare Partners LLC$12.5M
  • VOLORIDGE INVESTMENT MANAGEMENT, LLC$6.5M
  • Fieldview Capital Management, LLC$2.5M
  • OpenArc Corporate Advisory, LLC$2.3M
  • Schonfeld Strategic Advisors LLC$2.1M
  • Jain Global LLC$2.1M
  • Jump Financial, LLC$1.9M
  • Inspire Investing, LLC$1.7M

KNSA Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026265+17%62.00%+0.16 pp$2.93B+38%
Q1 2026226+1.8%61.84%7.10 pp$2.13B+23%
Q4 2025222+12%68.94%+12.88 pp$1.73B+13%
Q3 2025199+7.0%56.06%+1.07 pp$1.53B+46%
Q2 2025186+6.3%54.99%0.83 pp$1.05B+23%
Q1 2025175+12%55.82%+1.31 pp$848M+14%
Q4 20241569.8%54.51%1.18 pp$747M23%
Q3 2024173—55.69%—$967M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

How KNSA Compares to Peers

Institutional ownership and quarterly buying activity across the largest Immunology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
LKFTLakefront Biotherapeutics N.V.$2.19B49.6%79-12
YARWYarrow Bioscience Inc$145M1.2%47+2
RKTORocket One Inc.$9M7.9%22+3

KNSA — Frequently Asked Questions

Quick answers to the most common questions about buying KNSA stock.

What percentage of KNSA is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Kiniksa Pharmaceuticals International, plc stands at 62.0%, held across 265 reporting institutions.

Who is the largest institutional holder of KNSA?

FMR LLC is the largest reported institutional holder of KNSA, with approximately 6,971,361 shares worth $0.45B as of Q2 2026.

Is KNSA a hedge fund favorite?

Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of KNSA, including Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP.

What is KNSA's Smart Money Score?

Our composite Smart Money Score for KNSA is 65 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought KNSA this quarter?

65 institutions opened new positions in KNSA during Q2 2026, while 27 fully exited. 152 added to existing positions and 40 trimmed.

How is institutional ownership of KNSA changing?

KNSA institutional ownership rose by 0.16 percentage points quarter-over-quarter, with a net change of +39 holders.

How concentrated is KNSA ownership among the top holders?

The top 10 institutions account for 54.5% of all reported 13F value in KNSA, and the top 25 account for 74.7%.

How does KNSA compare to Immunology Biotech on institutional ownership?

Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.

Where does this KNSA institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

  • Hudson Bay Capital Management LP$1.3M
  • HUSSMAN STRATEGIC ADVISORS, INC.$1.0M
  • LANDSCAPE CAPITAL MANAGEMENT, L.L.C.$939K